[1]游紫萱,郑晓筱.逍遥蒌贝散对乳腺癌根治术患者外周血T淋巴细胞及引流液炎症指标的影响[J].陕西中医,2021,(2):183-186.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.012]
　YOU Zixuan,ZHENG Xiaoxiao.Effects of Xiaoyao Loubei powder on peripheral T lymphocytes and drainage fluid inflammatory indicators in patients undergoing radical mastectomy[J].,2021,(2):183-186.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.012]
点击复制

逍遥蒌贝散对乳腺癌根治术患者外周血T淋巴细胞及引流液炎症指标的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年2期
页码:
183-186
栏目:
临床研究
出版日期:
2021-02-05

文章信息/Info

Title:
Effects of Xiaoyao Loubei powder on peripheral T lymphocytes and drainage fluid inflammatory indicators in patients undergoing radical mastectomy
作者:
游紫萱; 郑晓筱
(成都中医药大学附属医院乳腺外科,四川 成都 610072)
Author(s):
YOU Zixuan; ZHENG Xiaoxiao
(Department of Breast Surgery,Affiliated Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu 610072,China)
关键词:
逍遥蒌贝散;  乳腺癌根治术;  外周T淋巴细胞;  白细胞介素;  肿瘤坏死因子
Keywords:
Xiaoyao Loubei powder;  Radical mastectomy;  Peripheral T lymphocytes;  IL;  TNF-α
分类号:
R 737.9
DOI:
DOI:10.3969/j.issn.1000-7369.2020.02.012
文献标志码:
A
摘要:
目的:探讨逍遥蒌贝散对乳腺癌根治术患者外周血T淋巴细胞及引流液炎症指标的影响。方法:选择128例乳腺癌根治术患者,随机分为对照组和观察组,每组64例,对照组术后给予CMF方案(环磷酰胺、甲氨蝶呤、5-氟尿嘧啶)化疗,观察组基于以上加逍遥蒌贝散治疗,观察两组治疗4周后的临床疗效,对比治疗前及治疗4周后的中医症候积分、外周血T淋巴细胞亚群水平、引流液炎症指标含量。结果:观察组的客观缓解率(ORR)为68.78%,显著高于对照组的50.00%(P<0.05); 治疗4周后,两组脘胁胀痛、食少、抑郁烦躁及太息共4项中医症候积分均显著低于治疗前(均P<0.05),观察组的外周血CD4+T淋巴细胞亚群占比及CD4+/CD8+T淋巴细胞亚群比值均显著高于治疗前(均P<0.05),两组引流液中白细胞介素(IL-8)、肿瘤坏死因子-α(TNF-α)含量均显著低于治疗前(均P<0.05),观察组变化幅度显著大于对照组(P<0.05)。结论:予逍遥蒌贝散治疗乳腺癌根治术后患者能提高临床疗效,缓解其相关中医症状,有效调节T淋巴细胞,减轻其引流液炎症反应。
Abstract:
Objective:To investigate the effects of Xiaoyao Loubei powder on peripheral T lymphocytes and drainage fluid inflammatory indicators in patients undergoing radical mastectomy.Methods: The data of 128 patients undergoing radical mastectomy for breast cancer were selected,and the patients were randomly divided into control group and observation group,with 64 cases in each group.Control group was given CMF chemotherapy regimen(cyclophosphamide,methotrexate,fluorouracil)after surgery,and observation group was given Xiaoyao Loubei powder on this basis.The clinical efficacy after 4 weeks of treatment was observed in the two groups,and the scores of TCM syndromes,levels of T lymphocyte subsets in peripheral blood and contents of inflammatory indicators in drainage fluid were compared before treatment and after 4 weeks of treatment.Results:The objective response rate(ORR)in observation group was significantly higher than that in control group(68.78% vs 50.00%,P<0.05).After 4 weeks of treatment,the scores of 4 items TCM syndromes of hypogastric pain,reduced appetite,depression and irritability and deep sigh in the two groups were significantly lower than those before treatment(all P<0.05).The proportion of peripheral blood CD4+T lymphocyte subsets and the ratio of CD4+/CD8+T lymphocyte subsets in the two groups were significantly higher than those before treatment(all P<0.05),and the contents of interleukin(IL-8)and tumor necrosis factor-α(TNF-α)in drainage fluid in the two groups were significantly lower than those before treatment(all P<0.05),and the changes in observation group were significantly greater than those in control group(all P<0.05).Conclusion:Xiaoyao Loubei powder for patients after radical mastectomy can improve the clinical efficacy,relieve the related TCM symptoms,effectively regulate T lymphocytes,and reduce the inflammatory response in drainage fluid.

参考文献/References:

[1] 宋希朋.乳腺癌术后常规化疗辅以中药治疗对患者远期转移复发率及生活质量的影响[J].现代中西医结合杂志,2016,25(33):3670-3672.
[2] 李 萌,尚 进,杨 波,等.贞芪扶正颗粒对乳腺癌术后化疗患者疗效及T淋巴细胞亚群的影响[J].解放军医药杂志,2018,30(9):12-15.
[3] 曾 丽,王 群.中药联合常规化疗对乳腺癌术后患者免疫功能及远期转移复发率的影响[J].解放军医药杂志,2016,28(11):98-101.
[4] 李巧玲,马 科,林 莹,等.马科辨证分型治疗乳腺癌术后临床经验[J].辽宁中医杂志,2018,45(10):2055-2057.
[5] 中国抗癌协会.新编常见恶性肿瘤诊治规范[M].北京:中国协和医科大学出版社,1999:9.
[6] 国家食品药品监督管理总局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:364-366.
[7] Eisenhauer EA,Therasse P,Bogaerts J,et al.New response evaluation criteria in solidtumours:Revised RECIST guideline(version 1.1)[J].Gan To Kagaku Ryoho,2009,36(13):2495-2501.
[8] 王子健,刘 芬,韩 捷,等.疏肝健脾方联合化疗治疗晚期三阴性乳腺癌临床疗效观察[J].世界中西医结合杂志,2020,15(5):154-157.
[9] 薛文武,谭婷婷.中医辨证治疗乳腺癌疗效及对患者癌症指标的影响研究[J].陕西中医,2018,39(3):338-340.
[10] 周晓慧,高 宏,殷东风.乳腺癌根治手术后冲任失调患者中医药治疗临床研究[J].辽宁中医药大学学报,2014,16(7):205-207.
[11] 陈 超,李华峰,谢洪玲.逍遥散对肝郁脾虚型乳腺癌患者辅助放疗的减毒增敏作用研究[J].中华全科医学,2017,11(15):142-144.
[12] 曾益玮,贾 颖.逍遥蒌贝散加减对乳腺癌围手术期术前患者进行干预[J].山西中医学院学报,2019,20(2):31-33,36.
[13] 徐 宁,王 皓.养正消积胶囊联合化疗对转移性乳腺癌的疗效及T淋巴细胞亚群水平的影响[J].贵阳中医学院学报,2018,43(3):345-348.
[14] 冯 斌,刘继红,冯 双,等.复方丹参注射液对乳腺癌根治术后患者早期引流液白细胞介素类细胞因子、疼痛及生活质量的影响[J].现代中西医结合杂志,2016,25(25):3889-3891.
[15] 杨 松,张琴琴,王婉雪,等.三七血伤宁胶囊对乳腺癌患者术后引流量及引流液中IL-8、TNF-α含量的影响[J].中医杂志,2019,60(9):760-763.
[16] 张 华,许凤燕.TNF-α及其受体与乳腺癌的研究进展[J].现代免疫学,2019,39(3):87-90.

备注/Memo

备注/Memo:
基金项目:四川省中医药科学技术研究专项(2016C038)
更新日期/Last Update: 2021-01-28